Development and partial characterization of a human T-lymphoblastic leukemic (CCRF-CEM) cell line resistant to etoposide. Analysis of possible circumventing approaches.

Flandina, C

Development and partial characterization of a human T-lymphoblastic leukemic (CCRF-CEM) cell line resistant to etoposide. Analysis of possible circumventing approaches. [electronic resource] - Journal of chemotherapy (Florence, Italy) Dec 1996 - 465-71 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1120-009X

10.1179/joc.1996.8.6.465 doi


Antineoplastic Agents, Phytogenic--pharmacology
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Etoposide--pharmacology
Humans
Leukemia, T-Cell--metabolism
Tumor Cells, Cultured--drug effects